X hits on this document

30 views

0 shares

0 downloads

0 comments

11 / 12

B. Amsden

CHEE 440

NEW DRUG SUBMISSION

NDS in Canada, ND Application in US

contents

all the preclinical and clinical data

includes pharmacokinetics and bioavailability, discussion of risk and benefits, complete proposed product labeling

HPFB and FDA rule on acceptability (2-4 years)

Document info
Document views30
Page views30
Page last viewedFri Dec 09 07:58:39 UTC 2016
Pages12
Paragraphs147
Words546

Comments